If you’ve ever been bitten by a tick you may have subsequently experienced symptoms of a rash, headache and fever that typically can last for up to four weeks. However, for some patients, tick-borne illness can have far-ranging and longer-term health implications stemming from the associated infection such as Bartonella, Ehrlichia, Babesia, or Anaplasma.
While you may not necessarily be familiar with the disorder “small fiber neuropathy (SFN)” it actually has a global prevalence of approximately four million individuals although the incidence is probably much higher than currently identified as quite often patients may not be fully evaluated for this condition.
Neurological effects post-COVID and what history tells us about post-viral syndromes.
Results from a large retrospective study of nearly 240,000 subjects recently published in The Lancet show that in the six months after becoming ill with COVID, approximately one-third of the surviving patients were diagnosed with at least one neurological or psychological condition.1
New study identifies low sun exposure as risk factor in pediatric-onset MS.
Lifestyles that keep us sofa-bound watching television, playing video games or sitting at a desk all day have definitely contributed to being labeled as the “indoor generation.”
As if the past year of ongoing challenges wasn’t enough, many of us have had to deal with the additional onslaught of even more trauma imposed by the recent winter storms. It really has been such a rough time for so many and we are concerned that these events can wreak havoc with our health, including our brain health, if left unchecked.
A new article in The JAMA Forum1 highlights increased concerns and should inspire more conversation about social determinants of health, described by the CDC as “conditions in the environments where people are born, live, learn, work, play, worship, and age that affect a wide range of health, functioning, and quality-of-life outcomes and risks.”
Autoimmunity occurs when immune system activity, primarily inflammation, is directed at healthy cells, tissues, or other inappropriate targets in the body.
It’s hard to believe we’ve endured almost a year of one of the most challenging times in our world’s collective history. Among many of the prevailing concerns has been the issue of school closures and limited in-person instruction and the impact on our children’s mental health.
If there is one thing to which we all can relate, it is the impact of the COVID 19 pandemic and the myriad of disease containment measures such as school closures, social distancing, and home quarantine – although certainly this is not the kind of relatable event we would want to connect us.
For patients and their families who must deal with the very challenging issues inherent to attention deficient and hyperactivity disorders (ADHD), there comes some welcome news in the way of innovative therapeutic options.
Dr. Suzanne Gazada, Integrative Neurology